NL6603433A - - Google Patents

Info

Publication number
NL6603433A
NL6603433A NL6603433A NL6603433A NL6603433A NL 6603433 A NL6603433 A NL 6603433A NL 6603433 A NL6603433 A NL 6603433A NL 6603433 A NL6603433 A NL 6603433A NL 6603433 A NL6603433 A NL 6603433A
Authority
NL
Netherlands
Application number
NL6603433A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6603433A publication Critical patent/NL6603433A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6603433A 1965-03-17 1966-03-16 NL6603433A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT240465A AT252264B (de) 1965-03-17 1965-03-17 Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates

Publications (1)

Publication Number Publication Date
NL6603433A true NL6603433A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-09-19

Family

ID=3533724

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6603433A NL6603433A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1965-03-17 1966-03-16

Country Status (6)

Country Link
US (1) US3396081A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT252264B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH485855A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1617447B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1088304A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6603433A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54132217A (en) * 1978-03-31 1979-10-15 Sunooden Kk Treating agent for autonomic disorder
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IE57931B1 (en) * 1983-10-11 1993-05-19 Fidia Spa Hyaluronic acid fractions having pharmaceutical activity,methods for preparation thereof,and pharmaceutical compositions containing the same
US5316926A (en) * 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
NO160722C (no) * 1983-11-25 1989-05-24 Miles Inc Fremgangsmaate for fremstilling av ultraren hyaluronsyre.
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US5099013A (en) * 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
IL78720A (en) * 1985-05-09 1990-01-18 Hill David Cullis Preparation of high-purity hyaluronic acid from synovial fluid
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
GB2228736A (en) * 1989-02-10 1990-09-05 Sterivet Lab Ltd Cosmetic formulation
JPH02215707A (ja) * 1989-02-15 1990-08-28 Chisso Corp 皮膚化粧料
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
AU2005209201B2 (en) * 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
WO2008094910A2 (en) * 2007-01-30 2008-08-07 Cypress Pharmaceutical, Inc. Hyaluronate compositions
US8609634B2 (en) 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US9579341B2 (en) 2007-05-16 2017-02-28 Johnson & Johnson Consumer Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
KR101789337B1 (ko) 2008-10-02 2017-10-23 엘.알.알.앤드 디 리미티드 계면층 상처 드레싱
US20100247606A1 (en) * 2009-03-25 2010-09-30 Allergan, Inc. Intraocular sustained release drug delivery systems and methods for treating ocular conditions
IT201700008651A1 (it) 2017-01-26 2018-07-26 Beauty System Pharma Ltd Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico
US11129862B2 (en) 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2662076A (en) * 1948-02-03 1953-12-08 Searle & Co Hyaluronidase inhibitors and the production thereof
US2599172A (en) * 1948-11-29 1952-06-03 Searle & Co Sulfuric acid esters of hyaluronic acid and processes for the production thereof
US3020204A (en) * 1960-05-11 1962-02-06 American Cyanamid Co Process for preparing augmentative intrinsic factor concentrate

Also Published As

Publication number Publication date
GB1088304A (en) 1967-10-25
DE1617447B1 (de) 1970-09-24
AT252264B (de) 1967-02-10
US3396081A (en) 1968-08-06
CH485855A (de) 1970-02-15

Similar Documents

Publication Publication Date Title
JPS454535Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4416681Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS448008Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4517891Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5133203Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4321087Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS432261Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4323581Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4815906Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4925157B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE674891A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675620A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675117A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675083A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675057A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675045A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL6609058A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL6617020A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675402A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675523A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675028A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE674893A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675529A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE667394A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)